New Mexico’s Health Care Consolidation Oversight Act: An Overview

On March 1, 2024, New Mexico joined a growing number of states in enacting legislation that increases oversight of certain health care transactions. Senate Bill 15 (S.B. 15), which adds a new section to the New Mexico Insurance Code (the Code) titled the “Health Care Consolidation Oversight Act” (the Act), takes effect on May 1, 2024.

Overview of the Act

The Act gives New Mexico’s Office of Superintendent of Insurance (the Office) the power to review and approve, conditionally approve, or disapprove proposed transactions involving New Mexico hospitals.

Like health care transaction review laws in other states covered in previous blog posts , the law is focused on the impact that hospital consolidations may have on access to services, health care quality, and costs. In particular, New Mexico’s law is concerned with acquisitions by larger hospital systems of smaller community hospitals, often in rural areas, that result in a change of control of the community hospital. These acquisitions will now be subject to the written approval of the Superintendent of Insurance (the Superintendent).

Transactions Subject to the Act

A “transaction” is defined to mean any of the following:

The term “control” means the power to direct or cause the direction of the management and policies of a hospital, whether directly or indirectly, including through the ownership of voting securities, through licensing or franchise agreements, or by contract other than a commercial contract for goods or nonmanagement services, unless the power is the result of an official position with or corporate office held by an individual. There is a presumption that control exists if a person, directly or indirectly, owns, controls, or holds 15% or more of the power to vote the voting securities of any other person. The presumption may be rebutted by the filing of a disclaimer of affiliation that control does not in fact exist in the manner provided by Section 59A-37-19 of the Code.

Notice of Proposed Transaction

The Act requires at least one person [iv] that is a party to a proposed transaction to submit a written notice to the Office in a form that the Office will prescribe.

The notice must include:

Although the law does not proscribe the effects on health care services in New Mexico that should be described in the notice, as described below, the law includes a list of factors that the Office may consider in its review (e.g., access, quality, costs, availability, etc.), which can be used as a guide.

All documents, materials or other information that are provided or disclosed to the Office in the course of a review under the Act are confidential.

Review of Proposed Transaction, Experts, and Costs

In conducting its review of a proposed transaction, the Office may consider the following:

The Office is permitted to retain actuaries, accountants, attorneys, or other professionals with expertise in the type of the proposed transaction to assist in conducting its review. The parties to the proposed transaction will be required to pay the reasonable costs and expenses incurred by the Office in the performance of its duties, including for costs associated with contracts with experts.

The Office will also consult with the Health Care Authority Department (the Authority) about the potential effect of the proposed transaction and incorporate the Authority’s recommendations into the Office’s final determination. Within 120 days of the Office receiving a complete notice of a proposed transaction, the Office is required to complete its review and consultation with the Authority and either approve, conditionally approve, or disapprove the proposed transaction. The time period will be tolled during any period during which the Office has requested and is waiting to receive additional information from the parties necessary to complete its review.

The Act provides that the Office shall approve the proposed transaction if it determines that -